Certara Weighs Regulatory Services Divestiture and Reports 17% Q4 Services Growth
Certara's CEO said the Regulatory Services unit is under review with a final decision planned within weeks, weighing divestiture against resource redeployment. The company reported a 1.5 book-to-bill ratio in December, 17% Q4 services bookings growth and maintained a 30–32% adjusted EBITDA margin outlook.
1. Strategic Review of Regulatory Services
Certara's Regulatory Services business has been in a strategic review since late 2025, with CEO Jon Resnick evaluating both outright sale and resource redeployment options. He aims to conclude the review within weeks, ensuring any outcome reflects the unit’s economic value and aligns with the company’s drug development focus.
2. Q4 Financial Performance and Guidance
CFO John Gallagher reported a December book-to-bill ratio of 1.5, 17% growth in Q4 services bookings and low-single-digit software bookings growth. Certara ended the year at a 32% adjusted EBITDA margin and forecasts 30–32% for 2026, citing plans for $10 million in cost avoidance alongside additional MIDD investments.
3. AI-Enabled Phoenix Cloud and QSP Software
Resnick highlighted Phoenix Cloud’s launch last year and adoption among Tier 1 clients, noting a strong pipeline for expanded rollouts. He also discussed Certara IQ, an AI-driven QSP technology expected to see faster uptake in services followed by broader software commercialization.